<--- Back to Details
First PageDocument Content
Genodermatoses / Von Hippel–Lindau disease / Von Hippel–Lindau tumor suppressor / Hemangioblastoma / Genetic testing / Health care in the United States / Health insurance / Health care / Genetic discrimination / Medicine / Health / Medical ethics
Date: 2012-05-10 21:46:42
Genodermatoses
Von Hippel–Lindau disease
Von Hippel–Lindau tumor suppressor
Hemangioblastoma
Genetic testing
Health care in the United States
Health insurance
Health care
Genetic discrimination
Medicine
Health
Medical ethics

VHL FAMILY FORUM Volume 18, Number 2

Add to Reading List

Source URL: vhl.org

Download Document from Source Website

File Size: 381,45 KB

Share Document on Facebook

Similar Documents

The genetic assessment of chemotypes - a fast method for the discrimination of agricultural Cannabis cultivars – and CANNDAT – an Austrian-German database surveying the distribution of chemotypes in European agricult

DocID: 1vlJF - View Document

Allison Campbell December 9, 2002 Biochem 118 Prof. Brutlag Implications of Genetic Discrimination: Who Should Know What?

DocID: 1vk3d - View Document

Continuing Studies course BIO 84: Your Genes and Your Health Professor Douglas L. Brutlag, Stanford University April 1, 2011 Polygenicity of Bipolar Disorders and Genetic Job Discrimination

DocID: 1uori - View Document

Genetic Discrimination In recent decades, research in biology has gradually led to a better understanding of the human genome, its structure and its functions.

DocID: 1tTCR - View Document

Notice of Non-Discrimination Wesley College does not discriminate against any person on the basis of race, color, national origin, sex, gender identity, sexual orientation, marital status, disability, age, genetic inform

DocID: 1taxJ - View Document